Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

F. De Vincenzo · SciRah

Researcher profile · Semantic Scholar

F. De Vincenzo

Share profile

F. De Vincenzo — researcher profile on SciRah

h-index: 21
Works: 93
Citations: 1,848

Most-cited papers

Phase II Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Cisplatin-Based Chemotherapy.
P. Zucali, T. De Pas, G. Palmieri, A. Favaretto +20 more
2014Journal of Clinical Oncology143 citations
Semantic Scholar
Retreatment with pemetrexed-based chemotherapy in patients with malignant pleural mesothelioma.
G. Ceresoli, P. Zucali, F. De Vincenzo, L. Gianoncelli +5 more
2011Lung Cancer130 citations
Semantic Scholar
Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials
G. Ceresoli, B. Castagneto, P. Zucali, A. Favaretto +12 more
2008British Journal of Cancer118 citations Open access
Semantic Scholar
Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma
G. Ceresoli, P. Zucali, M. Mencoboni, M. Botta +14 more
2013British Journal of Cancer109 citations Open access
Semantic Scholar
Advances in the biology of malignant pleural mesothelioma.
P. Zucali, G. Ceresoli, F. De Vincenzo, M. Simonelli +3 more
2011Cancer Treatment Reviews109 citations
Semantic Scholar
Phase II study of asparagine-glycine-arginine-human tumor necrosis factor alpha, a selective vascular targeting agent, in previously treated patients with malignant pleural mesothelioma.
V. Gregorc, P. Zucali, A. Santoro, G. Ceresoli +15 more
2010Journal of Clinical Oncology109 citations Open access
Semantic Scholar
Second-line chemotherapy in malignant pleural mesothelioma: results of a retrospective multicenter survey.
P. Zucali, M. Simonelli, G. Michetti, M. Tiseo +12 more
2012Lung Cancer99 citations
Semantic Scholar
Thymidylate Synthase and Excision Repair Cross-Complementing Group-1 as Predictors of Responsiveness in Mesothelioma Patients Treated with Pemetrexed/Carboplatin
P. Zucali, E. Giovannetti, A. Destro, M. Mencoboni +13 more
2011Clinical Cancer Research95 citations Open access
Semantic Scholar
Gemcitabine and vinorelbine in pemetrexed‐pretreated patients with malignant pleural mesothelioma
P. Zucali, G. Ceresoli, I. Garassino, F. De Vincenzo +6 more
2008Cancer94 citations Open access
Semantic Scholar
Early response evaluation in malignant pleural mesothelioma by positron emission tomography with [18F]fluorodeoxyglucose.
G. Ceresoli, A. Chiti, P. Zucali, F. De Vincenzo +7 more
2006Journal of Clinical Oncology66 citations
Semantic Scholar
Avelumab plus axitinib in unresectable or metastatic type B3 thymomas and thymic carcinomas (CAVEATT): a single-arm, multicentre, phase 2 trial.
F. Conforti, P. Zucali, L. Pala, C. Catania +15 more
2022The Lancet Oncology64 citations
Semantic Scholar
Clinical outcomes in patients receiving three lines of targeted therapy for metastatic renal cell carcinoma: results from a large patient cohort.
R. Iacovelli, G. Cartenì, C. Sternberg, M. Milella +20 more
2013European Journal of Cancer61 citations
Semantic Scholar
Assessment of tumor response in malignant pleural mesothelioma.
G. Ceresoli, A. Chiti, P. Zucali, F. Cappuzzo +6 more
2007Cancer Treatment Reviews57 citations
Semantic Scholar
Vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma.
P. Zucali, M. Perrino, E. Lorenzi, G. Ceresoli +6 more
2014Lung Cancer53 citations
Semantic Scholar
Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671).
C. Proto, M. Ganzinelli, S. Manglaviti, M. Imbimbo +39 more
2024Annals of Oncology43 citations Open access
Semantic Scholar
Gene methylation in pleural mesothelioma: correlations with clinico-pathological features and patient's follow-up.
A. Destro, G. Ceresoli, E. Baryshnikova, I. Garassino +8 more
2008Lung Cancer43 citations
Semantic Scholar
Reproducibility of the WHO classification of thymomas: practical implications
P. Zucali, L. di Tommaso, I. Petrini, S. Battista +11 more
2012Lung Cancer40 citations Open access
Semantic Scholar
Standard vs adapted sunitinib regimen in elderly patients with metastatic renal cell cancer: results from a large retrospective analysis.
U. de Giorgi, E. Scarpi, C. Sacco, M. Aieta +15 more
2014Clinical Genitourinary Cancer29 citations
Semantic Scholar
Immunotherapy with immune checkpoint inhibitors and predictive biomarkers in malignant mesothelioma: Work still in progress
M. Perrino, F. De Vincenzo, Nadia Cordua, F. Borea +3 more
2023Frontiers in Immunology27 citations Open access
Semantic Scholar
Lymphopenia and clinical outcome of elderly patients treated with sunitinib for metastatic renal cell cancer.
U. de Giorgi, K. Rihawi, M. Aieta, G. Lo Re +15 more
2014Journal of Geriatric Oncology24 citations
Semantic Scholar
Future developments in the management of malignant pleural mesothelioma
P. Zucali, F. De Vincenzo, M. Simonelli, A. Santoro
2009Expert Review of Anticancer Therapy24 citations
Semantic Scholar
Resound Trial: A phase 2 study of regorafenib in patients with thymoma (type B2‐B3) and thymic carcinoma previously treated with chemotherapy
M. Perrino, T. De Pas, S. Bozzarelli, L. Giordano +8 more
2021Cancer21 citations Open access
Semantic Scholar
Predictors of long-term response to abiraterone in patients with metastastic castration-resistant prostate cancer: a retrospective cohort study
E. Verzoni, U. de Giorgi, L. Derosa, O. Caffo +23 more
2016OncoTarget20 citations Open access
Semantic Scholar
Systemic treatments for thymic tumors: a narrative review
P. Zucali, F. De Vincenzo, M. Perrino, N. Digiacomo +4 more
2021Mediastinum19 citations Open access
Semantic Scholar
Prognostic and predictive role of [18F]fluorodeoxyglucose positron emission tomography (FDG‐PET) in patients with unresectable malignant pleural mesothelioma (MPM) treated with up‐front pemetrexed‐based chemotherapy
P. Zucali, E. Lopci, G. Ceresoli, L. Giordano +12 more
2017Cancer Medicine19 citations Open access
Semantic Scholar
Phase I and pharmacodynamic study of high-dose NGR–hTNF in patients with refractory solid tumours
P. Zucali, M. Simonelli, F. De Vincenzo, E. Lorenzi +12 more
2011British Journal of Cancer19 citations Open access
Semantic Scholar
Autoimmunity in thymic epithelial tumors: a not yet clarified pathologic paradigm associated with several unmet clinical needs
M. Perrino, E. Voulaz, Simone Balin, Gerardo Cazzato +22 more
2024Frontiers in Immunology15 citations Open access
Semantic Scholar
Phase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors.
M. Simonelli, P. Zucali, E. Lorenzi, Luca Rubino +14 more
2013European Journal of Cancer15 citations
Semantic Scholar
Prognostic factors in patients receiving third line targeted therapy for metastatic renal cell carcinoma.
R. Iacovelli, A. Farcomeni, C. Sternberg, G. Cartenì +22 more
2015Journal of Urology14 citations
Semantic Scholar
Thymic Epithelial Tumor and Immune System: The Role of Immunotherapy
M. Perrino, Nadia Cordua, F. De Vincenzo, F. Borea +6 more
2023Cancers13 citations Open access
Semantic Scholar
Oligoprogressive castration-resistant prostate cancer treated with metastases-directed stereotactic body radiation therapy: predictive factors for patients’ selection
C. Franzese, M. Perrino, M. Marzo, M. Badalamenti +6 more
2022Clinical and Experimental Metastasis13 citations Open access
Semantic Scholar
Rituximab in steroid-refractory immune-related pancreatitis: a case report
A. Santoro, Silvia Masini, R. Cavina, M. C. Tronconi +1 more
2023Frontiers in Oncology12 citations Open access
Semantic Scholar
Pulmonary sarcomatoid carcinoma presenting both ALK rearrangement and PD-L1 high positivity
Federica D'Antonio, R. de Sanctis, I. Bolengo, A. Destro +3 more
2019Medicine12 citations Open access
Semantic Scholar
Current Perspectives on Immunotherapy in the Peri-Operative Setting of Muscle-Infiltrating Bladder Cancer
P. Zucali, Nadia Cordua, Federica D'Antonio, F. Borea +3 more
2020Frontiers in Oncology11 citations Open access
Semantic Scholar
Response to sunitinib in an adult patient with rhabdoid renal cell carcinoma.
F. De Vincenzo, P. Zucali, G. Ceresoli, P. Colombo +7 more
2011Journal of Clinical Oncology10 citations
Semantic Scholar
Case Report of Acute Aortic Dissection during Treatment with Capecitabine for a Late Recurrence of Breast Cancer
F. Sclafani, C. Carnaghi, P. Colombo, S. Bozzarelli +4 more
2010Chemotherapy9 citations
Semantic Scholar
A phase II study of the combination of gemcitabine and imatinib mesylate in pemetrexed-pretreated patients with malignant pleural mesothelioma.
P. Zucali, M. Perrino, F. De Vincenzo, L. Giordano +3 more
2020Lung Cancer7 citations
Semantic Scholar
Role of chemotherapy in combination with hormonal therapy in first-line treatment of metastatic hormone-sensitive prostate cancer.
G. Ceresoli, F. De Vincenzo, M. Sauta, M. Bonomi +1 more
2015The Quarterly Journal of Nuclear Medicine and Molecular Imaging7 citations
Semantic Scholar
201 Treatment with gemcitabine and vinorelbine (GEMVIN) as second-line chemotherapy in pemetrexed-pretreated patients with malignant pleural mesothelioma (MPM)
P. Zucali, I. Garassino, G. Ceresoli, F. De Vincenzo +5 more
20067 citations
Semantic Scholar
Final results of DIADEM, a phase II study to investigate the efficacy and safety of durvalumab in advanced pretreated malignant pleural mesothelioma
S. Canova, G. Ceresoli, F. Grosso, P. Zucali +29 more
2022ESMO Open6 citations Open access
Semantic Scholar
9127 The role of thymidylate synthase (TS) and excision repair cross-complementing group 1 (ERCC1) immunohistochemical expression in malignant pleural mesothelioma patients treated with pemetrexed and carboplatin
P. Zucali, A. Destro, G. Ceresoli, L. Gianoncelli +6 more
20096 citations
Semantic Scholar
New target therapies in prostate cancer: from radioligand therapy, to PARP-inhibitors and immunotherapy.
Francesco Ceci, L. S. Airò Farulla, E. Bonatto, L. Evangelista +9 more
2024The Quarterly Journal of Nuclear Medicine and Molecular Imaging5 citations
Semantic Scholar
Sunitinib as first-line therapy in elderly patients (age 70 and older) with metastatic renal cell cancer.
U. de Giorgi, K. Rihawi, G. Lo Re, T. Sava +13 more
2012Journal of Clinical Oncology5 citations
Semantic Scholar
Perioperative Treatments in Pleural Mesothelioma: State of the Art and Future Directions
L. Cecchi, M. Aliprandi, F. De Vincenzo, M. Perrino +8 more
2025Cancers4 citations
Semantic Scholar
Advances in drug treatments for mesothelioma
P. Zucali, F. De Vincenzo, M. Perrino, N. Digiacomo +6 more
2022Expert Opinion on Pharmacotherapy4 citations
Semantic Scholar
A phase II study of regorafenib in patients with thymic epithelial tumours previously treated with chemotherapy.
M. Perrino, S. Bozzarelli, P. Zucali, T. De Pas +11 more
20183 citations
Semantic Scholar
Phase I trial of tivantinib in combination with carboplatin and pemetrexed as first-line treatment in patients with advanced nonsquamous non small cell lung cancer or malignant pleural mesothelioma.
P. Zucali, M. Simonelli, F. De Vincenzo, G. Fatuzzo +7 more
20153 citations
Semantic Scholar
P-394 Positron emission tomography with F18-fluorodeoxyglucose (FDG-PET) in malignant pleural mesothelioma (MPM): Prediction of response to chemotheraphy by quantitative assessment of standard uptake value (SUV)
G. Ceresoli, P. Zucali, R. Van Hemert, R. Cavina +6 more
20053 citations
Semantic Scholar
EFFECTIVENESS OF BISPHOSPHONATES AND DENOSUMAB ON RISK OF VERTEBRAL FRACTURES IN PROSTATE CANCER PATIENTS UNDER ANDROGEN-DEPRIVATION THERAPIES: A REAL-WORLD PROSPECTIVE STUDY.
A. Piasentier, M. Birtolo, B. Turci, W. Vena +13 more
2025Endocrine Practice2 citations
Semantic Scholar
Treatment response after induction therapy in advanced thymic tumors: results from the Italian nationwide TYME database.
Giovanni Leuzzi, F. Sabia, C. Proto, Giuseppe Lo Russo +29 more
2025Lung Cancer2 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

P. Zucali×41
Invite
P. Zucali — researcher profile on SciRah
M. Perrino×24
Invite
M. Perrino — researcher profile on SciRah
A. Santoro×22
Invite
A. Santoro — researcher profile on SciRah
G. Ceresoli×18
Invite
G. Ceresoli — researcher profile on SciRah

×16

Invite

M. Simonelli — researcher profile on SciRah

L. Giordano×14

Invite

L. Giordano — researcher profile on SciRah

Nadia Cordua×13

Invite

Nadia Cordua — researcher profile on SciRah

Invite

E. Lorenzi — researcher profile on SciRah

Invite

F. Borea — researcher profile on SciRah

L. Gianoncelli×8

Invite

L. Gianoncelli — researcher profile on SciRah

Invite

R. Cavina — researcher profile on SciRah

Federica D'Antonio×6

Invite

Federica D'Antonio — researcher profile on SciRah